These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8146889)

  • 1. Designer red cells.
    Wilson RB; Spitalnik SL
    Transfusion; 1994 Mar; 34(3):189-91. PubMed ID: 8146889
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusions to group O subjects of 2 units of red cells enzymatically converted from group B to group O.
    Lenny LL; Hurst R; Goldstein J; Galbraith RA
    Transfusion; 1994 Mar; 34(3):209-14. PubMed ID: 8146892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of red blood cells to group O.
    Fricker J
    Lancet; 1996 Mar; 347(9002):680. PubMed ID: 8596389
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preparation of transfusable human universal red blood cell with recombinant alpha-galactosidase].
    Gong F; Lü QS; You Y; Gao HW; Bao GQ; Gao X; Li SB; Li LL; Wang YL; Tian SG; Zhang ZX; Zhang P; Zhang YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):313-6. PubMed ID: 15854299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolysis from ABO Incompatibility.
    Simmons DP; Savage WJ
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The production of group O cells.
    Lenny LL; Goldstein J
    Biotechnology; 1991; 19():75-100. PubMed ID: 1664756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood transfusion reaction (especially red cell incompatibility) and examinations for its protection (author's transl)].
    Tohyama H
    Rinsho Byori; 1980 Feb; 28(2):93-101. PubMed ID: 6767868
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood transfusion and monitoring. Immediate transfusion reactions. Erythrocyte transfusion].
    Riche H
    Soins; 1996 Apr; (605):23-6. PubMed ID: 8716245
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of A2 reverse grouping cells from A2B red blood cells by alpha-galactosidase.
    Gao HW; Wu DZ; Li SB; Wang MN; Wang YL; Bao GQ; Ji SP; Tan YX; Xu H; Gong F
    Blood Transfus; 2013 Apr; 11(2):305-7. PubMed ID: 23149135
    [No Abstract]   [Full Text] [Related]  

  • 10. Conversion of ABO blood groups.
    Goldstein J
    Transfus Med Rev; 1989 Jul; 3(3):206-12. PubMed ID: 2562478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying the red cell surface: towards an ABO-universal blood supply.
    Olsson ML; Clausen H
    Br J Haematol; 2008 Jan; 140(1):3-12. PubMed ID: 17970801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic factors in reactions to blood transfusions.
    McLeod BC
    Heart Lung; 1980; 9(4):675-81. PubMed ID: 6773907
    [No Abstract]   [Full Text] [Related]  

  • 13. [Significance of blood groups in surgical practice].
    Dutkevich IG; Golovin GV
    Vestn Khir Im I I Grek; 1989 Jun; 142(6):92-5. PubMed ID: 2510392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice are unsuitable for modelling ABO discordance despite strain-specific A cross-reactive natural IgM.
    Larkin JM; Porter CD
    Br J Haematol; 2005 Jul; 130(2):310-7. PubMed ID: 16029461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The two antibody specificities within human anti-blood group B antibodies.
    Galili U
    Transfus Med Rev; 1988 Jun; 2(2):112-21. PubMed ID: 2485158
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion medicine illustrated. Detection of mixed-field agglutination due to loss of red cell antigen in hematopoietic malignancy.
    Sheppard CA; O'Reilly KC; Schniederjan SD; Hillyer CD; Roback JD
    Transfusion; 2006 Sep; 46(9):1463-4. PubMed ID: 16965568
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventing ABO incompatible blood transfusion.
    Wallis JP
    Br J Haematol; 2006 Feb; 132(4):531; author reply 532. PubMed ID: 16412027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythrocyte substitution and isoagglutinin titer following ABO-incompatible bone marrow transplantation].
    Henneberg-Quester KB; Luboldt W; Schaefer UW; Beelen DW; Quabeck K
    Beitr Infusionsther; 1990; 26():200-4. PubMed ID: 1703830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nearly two decades using the check-type to prevent ABO incompatible transfusions: one institution's experience.
    Figueroa PI; Ziman A; Wheeler C; Gornbein J; Monson M; Calhoun L
    Am J Clin Pathol; 2006 Sep; 126(3):422-6. PubMed ID: 16880143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On the problem of prevention of complications, caused by transfusion of ABO-incompatible blood].
    Maksimov PM
    Probl Gematol Pereliv Krovi; 1967 Mar; 12(3):53-6. PubMed ID: 5619484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.